Sanofi India Ltd

NSE: SANOFI · BSE: 500674 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹3,022.10
Market cap: ₹6,960 Cr
Revenue (annual): ₹1,837 Cr
Net profit (annual): ₹326.7 Cr
P/E (TTM): 21.5×Sector 47.4×
Promoter holding: 60.40%+0.00% QoQ
FII holding: 5.69%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 11 Management Change 6 Financial Results 3 Earnings Call 3 Promoter Buying (Off-Market) 2 Annual General Meeting 2 Promoter Selling (Off-Market) 1 Other Announcement 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Aug 2026 20:11 IST BSE

Financial Results

Sanofi India Q1 FY27 Results: Net Profit ₹83.5 Cr, Up 20.1% YoY

Sanofi India Ltd reported revenue from operations of ₹437.7 Cr (+7.7% YoY) and net profit of ₹83.5 Cr (+20.1% YoY) for Q1 FY27.

Key figure: Net profit ₹83.5 Cr · +20.1% YoY

Open full results → Read the filing ↗

28 Apr 2026 18:37 IST NSE

Financial Results

Sanofi India Q4 FY26 Results: Net Profit ₹102.6 Cr, Down 14.1% YoY

Sanofi India Ltd reported revenue from operations of ₹472.3 Cr (-11.9% YoY) and net profit of ₹102.6 Cr (-14.1% YoY) for Q4 FY26.

Key figure: Net profit ₹102.6 Cr · -14.1% YoY

Open full results → Read the filing ↗

28 Apr 2026 18:36 IST NSE

Financial Results

Sanofi India Financial Results

Sanofi India Limited reported a total income of ₹476.7 Crore for the quarter ended March 31, 2026. Net profit for the period stood at ₹102.6 Crore. The company also announced the appointment of Mr. Rahul Bhatnagar as Chairman, effective April 30, 2026, following the completion of tenures for two independent directors.

Value: ₹476.7 Cr

Read the filing ↗